Independent and Coordinate Regulation of IL3 and Gmcsf

Taylor, Douglas S.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Heart, Lung, and Blood Institute (NHLBI)
• Type: Clinical Investigator Award (CIA) (K08)
• Project #: 1K08HL003483-01
• Application #: 2211750
• Study Section: Research Training Review Committee (RTR)
• Project Start: 1996-02-01
• Project End: 2001-01-31
• Budget Start: 1996-02-01
• Budget End: 1997-01-31
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: Dana-Farber Cancer Institute
• DUNS #: 149617367
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02215

Publications

Taylor, D S; Lee, Y; Sieff, C A et al. (1998) Phase I/II trial of PIXY321 (granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein) for treatment of inherited and acquired marrow failure syndromes. Br J Haematol 103:304-7